Key result
Catheter ablation in competitive athletes links to an ~87% lower PVC burden versus leisure athletes.
Why the study?
The management of symptomatic or high-burden PVCs in athletes remains controversial, and data on procedural efficacy, safety, and functional recovery after catheter ablation in this population are limited.
Does radiofrequency catheter ablation effectively reduce PVC burden and facilitate return to sport in competitive versus leisure-time athletes without structural heart disease?
Cohort (n=100)
No
Does radiofrequency catheter ablation effectively reduce PVC burden and facilitate return to sport in competitive versus leisure-time athletes without structural heart disease?
Radiofrequency catheter ablation is a safe and highly effective treatment for idiopathic PVCs in athletes without structural heart disease, significantly reducing arrhythmic burden and facilitating return to sport.
Answers are grounded in this paper and cite their sources.
CA may support return to sport after ablation in athletes with PVCs; leaves open need for prospective trials to confirm outcomes.
Background Premature ventricular contractions (PVCs) are frequently observed in athletes and are usually idiopathic and benign, most commonly arising from the right or left ventricular outflow tract (RVOT/LVOT) or fascicular system. However, the management of symptomatic or high-burden PVCs in athletes remains controversial, especially regarding eligibility and timing of return to sport after catheter ablation (CA). Data on procedural efficacy, safety and functional recovery in this population are still limited. Purpose To compare the efficacy, safety and functional outcomes of radiofrequency CA of idiopathic PVCs in competitive and leisure-time athletes without structural heart disease (SHD). Methods This single-centre retrospective study included 100 athletes aged ≥14 years who underwent CA for idiopathic PVCs between March 2019 and February 2025. All had preserved left ventricular ejection fraction and no SHD. Late gadolinium enhancement on cardiac MRI was allowed when unrelated to PVC origin or underlying cardiomyopathy. Patients were categorised as competitive (n=46) and leisure-time (n=54) athletes. Standard assessment included ECG, echocardiography and maximal exercise testing. Ablation was performed using a 3D electroanatomical mapping system. Follow-up included 24-hour Holter monitoring at 3–6 months and clinical evaluation at 9–15 months. Primary endpoint: PVC burden reduction. Secondary endpoint: return to sport. Results Competitive athletes were younger (29.7 ± 13 vs 44.5 ± 14.3 years, p<0.001) and predominantly male (80% vs 52%, p=0.002). RVOT was the most frequent PVC origin in both groups (54% vs 48%, p=ns). Baseline PVC burden was higher in leisure-time athletes (median 19 807 vs 10 750 PVCs/24 h, p=0.009). Acute procedural success was comparable (89% vs 83%, p=ns). Two minor complications occurred, one per group: a left bundle branch block and a vascular pseudoaneurysm. No major complications were observed. At follow-up, PVC burden decreased significantly in both groups, more markedly in competitive athletes (median 34.5 vs 274 PVCs/24 h, p=0.006). Return to sport occurred in 78% of competitive and 70% of leisure-time athletes (p=0.370), with 47% resuming competitive activity. Approximately 60% of the total cohort reported symptomatic improvement during sports participation. Conclusions Radiofrequency CA of idiopathic PVCs in athletes without SHD is a safe and highly effective option, irrespective of training level. Competitive athletes experienced a greater reduction in arrhythmic burden and a more complete functional recovery, supporting CA as a key component in managing symptomatic idiopathic PVCs and facilitating safe sport requalification.
No takes yet. Share an insight, caveat, or question.
Cardinali et al. (2026) conducted a cohort in Idiopathic premature ventricular contractions (n=100). Competitive athlete status vs. Leisure-time athlete status was evaluated on PVC burden reduction (p=0.006). Following catheter ablation for idiopathic PVCs, competitive athletes achieved a lower follow-up PVC burden compared to leisure-time athletes (median 34.5 vs 274 PVCs/24 h; p=0.006).
Synapse has enriched 10 related papers. Consider them for comparative context: